How foreign direct investment controls impact M&A transactions and investments in the LSH sector

Please join us for an exclusive one-hour webinar, where we will dive into the intricate world of the foreign direct investment (FDI) regulation, and unravel the complexities of FDI controls and their significant influence on M&A transactions and investments within the Life Sciences and Healthcare sector.

Our panel of experts will help you navigate the evolving FDI landscape, providing you with the foresight to understand how FDI controls are shaping the timing and implementation process of foreign investments. Their valuable guidance and practical insights will help you to anticipate challenges and strengthen your position in face of potential regulatory hurdles, ensuring successful M&A transactions and investments in the Life Sciences and Healthcare sector. Don't miss this opportunity and register now!

After registering you will be able to download the webinar details to save to your calendar. Joining instructions are included within the download file. You will also receive these details by email prior to the webinar.

Future Life Sciences Academy Webinars:

• How Regulatory and IP Issues Can Impact the Process for Acquiring/Divesting Life Sciences Companies in Europe - 29th October 2024 Register form - 29th October
• Key Lessons for Life Sciences from the First 18 Months of the UPC - 19th November 2024  Registration form - 19 Nov (vuturevx.com)
• Unveiling AI in Pharma & MedTech: From AI Protection to AI Innovation Through Case Studies in the Pharma & MedTech Industries - 10th December 2024 Registration form - 10 Dec (vuturevx.com)

Watch our previous LS Academy webinars

• Essential Safeguards: Preparing for Your Licensor's Bankruptcy in License Agreements (16th July 2024) - Essential Safeguards: Preparing for Your Licensor’s Bankruptcy in License Agreements (4623101) (on24.com)